Endostar injection inhibits rabbit ear hypertrophic scar formation

International Journal of Lower Extremity Wounds

Volumn 11, Issue 4, 2012, Pages 271-276

  Zhiyong, Wang ^a   Fei, Song ^a   Lianju, Xu ^a   Yingkai, Liu ^a   Chun, Qing ^a   Shuliang, Lu ^a   Xiqiao, Wang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Endostar; hypertrophic scar; microvessel; rabbit ear

Indexed keywords

CD34 ANTIBODY; COLLAGEN; EOSIN; HEMATOXYLIN; MATRIGEL; RECOMBINANT ENDOSTATIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; EAR; ENDOTHELIUM CELL; FEMALE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT;

ANALYSIS OF VARIANCE; ANIMALS; BIOPSY, NEEDLE; CICATRIX, HYPERTROPHIC; DISEASE MODELS, ANIMAL; EAR, EXTERNAL; ENDOSTATINS; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INJECTIONS, INTRALESIONAL; MALE; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 84870814609     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734612463698     Document Type: Article

References (15)

1. O'Leary R, Wood EJ, Guillou PJ. Pathological scarring: strategic interventions. Eur J Surg. 2002 ; 168: 523-534 (Pubitemid 36207752)
2. Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg. 2008 ; 206: 719-730
3. Bloemen MC, van der Veer WM, Ulrich MM, van Zuijlen PP, Niessen FB, Middelkoop E. Prevention and curative management of hypertrophic scar formation. Burns. 2009 ; 35: 463-475
4. Dixelius J, Larsson H, Sasaki T, et al. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood. 2000 ; 95: 3403-3411 (Pubitemid 30428470)
5. Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS. Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol. 2011 ; 12: 1101-1116
6. Kim KS, Kim DS, Chung KH, Park YS. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes. Cancer Gene Ther. 2006 ; 13: 563-571
7. Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, Mustoe TA. Temporal expression of the transforming growth factor-beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surg. 2007 ; 205: 78-88 (Pubitemid 47016969)
8. Bertolini F, Fusetti L, Mancuso P, et al. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anticd20 therapy in a NOD/SCID mouse model of human high grade non-Hodgkin lymphoma. Blood. 2000 ; 96: 282-287 (Pubitemid 30456483)
9. Hajitou A, Grignet C, Devy L, et al. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J. 2002 ; 16: 1802-1804
10. MacDonald NJ, Shivers WY, Narum DL, et al. Endostatin binds tropomyosin: a potential modulator of the antitumor activity of endostatin. J Biol Chem. 2001 ; 276: 25190-25196
11. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997 ; 88: 277-285 (Pubitemid 28015876)
12. Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagen gene expression in kloids:co-localization of type I and VI transforming growth factor-betal mRNA. J Invest Dermatol. 1991 ; 97: 240-248
13. Xi-Qiao W, Ying-Kai L, Chun Q, Shu-Liang L. Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring. Microvasc Res. 2009 ; 77: 204-211
14. Saphir A. Angiogenesis: the underlying concept in cancer?. J Natl Cancer lnst. 1997 ; 89: 1658-1659
15. Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem. 1999 ; 274: 11721-11726